# Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i Treatment

> **NCT01364701** · PHASE4 · UNKNOWN · sponsor: **Rambam Health Care Campus** · enrollment: 30 (estimated)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Sildenafil 100 mg
- **DRUG:** Tadalafil 20 mg
- **DRUG:** Combination half of maximal dose for sildenafil & tadalafil

## Key facts

- **NCT ID:** NCT01364701
- **Lead sponsor:** Rambam Health Care Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-06
- **Primary completion:** 2012-06
- **Final completion:** 2012-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2011-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364701, "Evaluation of Safety and Effectiveness of 2 Lower Dose Combined PDE5i's Versus Single Maximal Dose PDE5i Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01364701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*